1. Home
  2. PCVX vs LEA Comparison

PCVX vs LEA Comparison

Compare PCVX & LEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • LEA
  • Stock Information
  • Founded
  • PCVX 2013
  • LEA 1917
  • Country
  • PCVX United States
  • LEA United States
  • Employees
  • PCVX N/A
  • LEA N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • LEA Auto Parts:O.E.M.
  • Sector
  • PCVX Health Care
  • LEA Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • LEA Nasdaq
  • Market Cap
  • PCVX 4.4B
  • LEA 5.1B
  • IPO Year
  • PCVX 2020
  • LEA N/A
  • Fundamental
  • Price
  • PCVX $32.70
  • LEA $102.41
  • Analyst Decision
  • PCVX Strong Buy
  • LEA Buy
  • Analyst Count
  • PCVX 10
  • LEA 11
  • Target Price
  • PCVX $136.50
  • LEA $115.36
  • AVG Volume (30 Days)
  • PCVX 1.3M
  • LEA 717.7K
  • Earning Date
  • PCVX 08-06-2025
  • LEA 07-25-2025
  • Dividend Yield
  • PCVX N/A
  • LEA 3.01%
  • EPS Growth
  • PCVX N/A
  • LEA N/A
  • EPS
  • PCVX N/A
  • LEA 8.57
  • Revenue
  • PCVX N/A
  • LEA $22,889,700,000.00
  • Revenue This Year
  • PCVX N/A
  • LEA N/A
  • Revenue Next Year
  • PCVX N/A
  • LEA $2.56
  • P/E Ratio
  • PCVX N/A
  • LEA $11.95
  • Revenue Growth
  • PCVX N/A
  • LEA N/A
  • 52 Week Low
  • PCVX $27.66
  • LEA $73.85
  • 52 Week High
  • PCVX $121.06
  • LEA $119.10
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 47.81
  • LEA 58.33
  • Support Level
  • PCVX $29.08
  • LEA $95.27
  • Resistance Level
  • PCVX $34.50
  • LEA $109.38
  • Average True Range (ATR)
  • PCVX 1.38
  • LEA 2.28
  • MACD
  • PCVX -0.18
  • LEA 0.63
  • Stochastic Oscillator
  • PCVX 48.69
  • LEA 88.76

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.

Share on Social Networks: